Relapsed/Refractory CLL/SLL: Overcoming Resistance to Covalent BTKi and/or BCL2 Inhibitors |
0.50 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Management of Toxicities of BTK Inhibitors in B-Cell Malignancies |
0.75 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Bone Disease Management and Infections in Multiple Myeloma |
1.00 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Chronic Myeloid Leukemia/Myelofibrosis: TKI Therapy and Toxicity Management |
0.75 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Management of Graft-Versus-Host Disease in Hematopoietic Cell Transplant Recipients |
0.50 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Management of Lower-Risk Myelodysplastic Syndromes |
0.50 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Management of Waldenström Macroglobulinemia |
0.50 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Updates in the Management of Myelofibrosis |
0.50 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Archived Monthly Oncology Tumor Boards: Management of Recurrent/Metastatic Cervical Cancer and Neuroendocrine Carcinoma of the Cervix |
1.00 |
12/05/2023 - 12:00am to 12/05/2024 - 12:00am |
Archived Monthly Oncology Tumor Boards: Management of Advanced Ovarian Cancer |
1.00 |
12/09/2023 - 12:00am to 12/09/2024 - 12:00am |
NCCN Guidelines® Insights - Cervical Cancer, Version 1.2024 |
1.00 |
12/10/2023 - 12:00am to 12/10/2024 - 12:00am |
Immunotherapy in Hepatocellular Carcinoma: Improving the Treatment Paradigm Within Community Practice |
1.00 |
12/19/2023 - 12:00am to 12/19/2024 - 12:00am |
Recorded Presentation from the NCCN Pharmacy Updates: Advances in Targeted Therapy for Biliary Tract Cancers |
1.00 |
12/19/2023 - 12:00am to 12/14/2024 - 12:00am |
Advances in the Management of Metastatic Castration-Resistant Prostate Cancer: Expert Guidance and Resources for the Interdisciplinary Team |
1.25 |
12/21/2023 - 12:00am to 12/21/2024 - 12:00am |
Applying the Latest Evidence and NCCN Guideline Recommendations in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma |
2.00 |
12/21/2023 - 12:00am to 12/21/2024 - 12:00am |